![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, August 15, 2013 4:11:58 PM
The CE mark is a significant milestone. Those on both sides of the argument seem to clearly believe this. With all of the arguments against SNDY, it is clear all believe this to be a big achievement for the company and a lot of money and dilution has gone into ensuring this would happen. So all sides including the company believe this is a big achievement.
Will this CE mark generate significant revenue? Not by itself but it opens markets. Who will be selling this product and who will be buying these products? Who knows at this point. I haven't seen a real answer but it would be a prerequisite to sell the company or merge.
I also don't see anyone arguing that mammoview does not work. So that would be the biggest and best argument to me but it is pretty obvious to me and from reading some of the technical docs, that it probably does work. How come it hasn't been picked up more my others, journals, every hospital in the free world wanting it? Does make you wonder.
I don't see any real short volume and I am not sure you even could short this stock. The downside and upside and the fees probably make this a poor choice.
Is the argument really about a trading opportunity and entry price? Probably, at least it would seem that way.
Buyout? For the tech maybe but the trading wouldn't indicate it so far from what I can see but maybe with CE mark as some are predicting.
Will I buy some more shares? Probably
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM